Seven Fleet Capital Management »

Cue Biopharma shares owned by Seven Fleet Capital Management

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Seven Fleet Capital Management from 13F filings

Historical chart of Seven Fleet Capital Management investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Seven Fleet Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Seven Fleet Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $338k 11k 31.56

More positions owned by Seven Fleet Capital Management

Cg Oncology (CGON)
Tango Therapeutics (TNGX)
Revolution Medicines (RVMD)
Pharvaris N V (PHVS)
Liquidia Corporation Com New (LQDA)
Enliven Therapeutics (ELVN)
Abivax Sa Sponsored Ads (ABVX)
Avalo Therapeutics Com New (AVTX)
Mirum Pharmaceuticals (MIRM)
Assembly Biosciences Com New (ASMB)
Century Therapeutics (IPSC)
Cytokinetics Com New (CYTK)
Taysha Gene Therapies Com Shs (TSHA)
Veradermics Common Stock (MANE)
Arrivent Biopharma (AVBP)

View all positions for Seven Fleet Capital Management

Top funds holding Cue Biopharma

Bleichroeder
Driehaus Capital Management
Vanguard Capital Management
Ikarian Capital
Polygon Management
Stempoint Capital
BlackRock
ADAR1 Capital Management
Lion Point Capital
Squadron Capital Management
Diadema Partners
Geode Capital Management
Belvedere Trading
Boothbay Fund Management
UBS Group

View all funds holding Cue Biopharma